Construction Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Construction Press Releases.

Press releases published on May 30, 2026

May 30, 2026

Bison Plumbing Earns Continued Recognition From ThreeBestRated® for Trusted Plumbing Services in Southeast Michigan

Indeterminate EIN Presswire

May 30, 2026

Level Home Brings Commercial and Pre-Construction Pier Services to Oklahoma

Indeterminate EIN Presswire

May 30, 2026

Level Home Reports Surge in Foam Injection and Crawl Space Repair Demand

Indeterminate EIN Presswire

May 30, 2026

Oklahoma Clay Soil Drives Record Foundation Repair Demand in Tulsa

Indeterminate EIN Presswire

May 30, 2026

Pier and Beam Repair Demand Rises Across Tulsa's Older Neighborhoods

Indeterminate EIN Presswire

May 30, 2026

Level Home Foundation Repair Reaches 179 Five-Star Reviews in Tulsa

Indeterminate EIN Presswire

May 30, 2026

Helical Pier Demand Grows as Oklahoma Clay Soil Challenges Builders

Indeterminate EIN Presswire

16 hours ago

Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours

Indeterminate GlobeNewswire

16 hours ago

Orion Pharma julkisti ensimmäiset tulokset Faasi 1/2 TEADES-tutkimuksesta ODM-212-molekyylillä (TEAD-estäjä) potilailla, joilla on kiinteitä kasvaimia ja edennyt syöpä

Indeterminate GlobeNewswire

16 hours ago

Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology

Indeterminate GlobeNewswire

16 hours ago

Globale Daten der ROSETTA Lung-02-Studie: Ermutigende Wirksamkeit für BioNTechs und Bristol Myers Squibbs bispezifischen PD-L1xVEGF-A-Immunmodulator-Kandidat Pumitamig bei nicht-kleinzelligem Lungenkrebs

Indeterminate GlobeNewswire

16 hours ago

Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

Indeterminate GlobeNewswire

18 hours ago

ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026

Indeterminate GlobeNewswire

May 30, 2026

Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)

Indeterminate GlobeNewswire

May 30, 2026

Vapofil Reviews [URGENT REPORT 2026] The Shocking VapoFil Male Enhancement Supplement Trend Everyone Is Talking About

Indeterminate GlobeNewswire

May 30, 2026

ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

Indeterminate GlobeNewswire

May 30, 2026

AI Market Cap Crosses $26 Billion as Ruvi AI (RUVI) Unveils Major Platform Upgrade and New Proprietary Technology

Indeterminate GlobeNewswire

May 30, 2026

World Vape Day 2026: One Switch – Everyone Wins

Indeterminate GlobeNewswire

May 30, 2026

Día Mundial del Vapeo 2026: Un cambio: todos ganan

Indeterminate GlobeNewswire

May 30, 2026

Hari Vape Sedunia 2026: Satu Peralihan – Kemenangan untuk Semua

Indeterminate GlobeNewswire